combin trial human lymphoblastoid interferon bestrabucil adult t-cell leukemia-lymphoma human lymphoblastoid interferon hlbi bestrabucil conjug chlorambucil beta-estradiol activ adult t-cell leukemia-lymphoma atll vitro studi agent synergist antiprolif effect cell line author clinic efficaci combin pilot studi poor-risk group atll patient patient IU hlbi mg bestrabucil patient lymphoma-typ atll hypercalcemia prednisolon patient suitabl evalu partial respons minor respons respons patient skin infiltr patient hypercalcemia histori prior chemotherapi respons rate time clinic respons day median day initi treatment respons durat week median week patient treatment seriou side effect respons rate combin treatment high respons durat short treatment control aggress diseas 